Yamauchi et al. [22]: a prospective single-center study assessing the urinary levels of prostaglandin E2 (PGE2), prostaglandin F2α (PGF2a), NGF and substance p in patients with suprapontine brain diseases (n = 114) and controls (n = 27). The gene discussed is TAC1; the disease is brain disorder.